• Skip to main content
  • Skip to footer

University of Tennessee Research Foundation

Technology Transfer & Licensing

  • About
    • Our Mission
    • Foundation History & Details
    • Student Opportunities
    • Frequently Asked Questions
    • UTRF Staff
    • Projects & Partners
  • Technologies
    • Available Technologies
    • Express Licensing
  • For Innovators
    • UT Research Foundation Accelerator Fund
    • Resources
    • IDEA Tutorial & Manuals
    • Technology Transfer Process
    • Business Incubator
    • UTRF Technology Maturation Grant Funding
  • Industry
    • Industry Partnerships
    • Agreement Examples
  • Media
    • News
    • Newsletters
    • Tech Talks
    • Annual Reports
  • Contact

Inventions & Patents

UTRF Administrator / May 29, 2023

University of Tennessee Research Foundation, California Institute of Technology secure patent for UT startup’s pancreatic cancer drug

Over half a million people die from cancer every year, according to current statistics. For those diagnosed with pancreatic cancer, the current five-year …

[Read more...] about University of Tennessee Research Foundation, California Institute of Technology secure patent for UT startup’s pancreatic cancer drug

UTRF Administrator / April 23, 2023

Long-term vision and partnership: UTRF startup to develop next-generation RNA medicines using a novel drug delivery system

Around a decade ago, a researcher at the University of Tennessee Graduate School of Medicine (UTSGM) and a graduate student in her lab began to imagine creating …

[Read more...] about Long-term vision and partnership: UTRF startup to develop next-generation RNA medicines using a novel drug delivery system

UTRF Administrator / April 21, 2022

UTRF Licensee Veru, Inc. Announces Positive Results of COVID-19 Therapy’s Phase 3 Clinical Study, Seeking Emergency Use Authorization from FDA

UT Research Foundation licensee Veru, Inc. announced on April 11, 2022, that their Phase 3 clinical trial of sabizabulin as an oral therapy for hospitalized …

[Read more...] about UTRF Licensee Veru, Inc. Announces Positive Results of COVID-19 Therapy’s Phase 3 Clinical Study, Seeking Emergency Use Authorization from FDA

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 13
  • Go to Next Page »

Footer

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Multi Campus Office

400 W. Summit Hill Drive
UT Tower 961A
Knoxville, TN 37902
Phone: 865-974-1882

Health Science Center

UT Health Science Center
910 Madison Avenue, Suite 827
Memphis, TN 38163
Phone: 901-448-7827


Copyright © 2023


University of Tennessee Campuses & Institutes

  • UT Knoxville
  • UT Chattanooga
  • UT Southern
  • UT Martin
  • UT Health Science Center
  • UT Institute of Agriculture
  • UT Institute for Public Service
  • UT Alumni Association
  • UT Foundation
  • UT Research Park
X